Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Sweden 2000–2003, increasing incidence and regional differences

<p>Abstract</p> <p>Background</p> <p>The occurrence of methicillin-resistant <it>Staphylococcus </it>aureus (MRSA) has gradually become more frequent in most countries of the world. Sweden has remained one of few exceptions to the high occurrence of MRSA in...

Full description

Bibliographic Details
Main Authors: Olsson-Liljequist Barbro, Larsson Leif, Ringberg Håkan, Örtqvist Åke, Stenhem Mikael, Hæggman Sara, Ekdahl Karl
Format: Article
Language:English
Published: BMC 2006-02-01
Series:BMC Infectious Diseases
Online Access:http://www.biomedcentral.com/1471-2334/6/30
id doaj-4cb6194533434a6d84484a72a70a1aef
record_format Article
spelling doaj-4cb6194533434a6d84484a72a70a1aef2020-11-25T03:52:15ZengBMCBMC Infectious Diseases1471-23342006-02-01613010.1186/1471-2334-6-30Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Sweden 2000–2003, increasing incidence and regional differencesOlsson-Liljequist BarbroLarsson LeifRingberg HåkanÖrtqvist ÅkeStenhem MikaelHæggman SaraEkdahl Karl<p>Abstract</p> <p>Background</p> <p>The occurrence of methicillin-resistant <it>Staphylococcus </it>aureus (MRSA) has gradually become more frequent in most countries of the world. Sweden has remained one of few exceptions to the high occurrence of MRSA in many other countries. During the late 1990s, Sweden experienced a large health-care associated outbreak which with resolute efforts was overcome. Subsequently, MRSA was made a notifiable diagnosis in Sweden in 2000.</p> <p>Methods</p> <p>From the start of being a notifiable disease in January 2000, the Swedish Institute for Infectious Disease Control (SMI) initiated an active surveillance of MRSA.</p> <p>Results</p> <p>The number of reported MRSA-cases in Sweden increased from 325 cases in 2000 to 544 in 2003, corresponding to an overall increase in incidence from 3.7 to 6.1 per 100000 inhabitants. Twenty five per cent of the cases were infected abroad. The domestic cases were predominantly found through cultures taken on clinical indication and the cases infected abroad through screening. There were considerable regional differences in MRSA-incidence and age-distribution of cases.</p> <p>Conclusion</p> <p>The MRSA incidence in Sweden increased over the years 2000–2003. Sweden now poises on the rim of the same development that was seen in the United Kingdom some ten years ago. A quarter of the cases were infected abroad, reflecting that international transmission is now increasingly important in a low-endemic setting. To remain in this favourable situation, stepped up measures will be needed, to identify imported cases, to control domestic outbreaks and to prevent transmission within the health-care sector.</p> http://www.biomedcentral.com/1471-2334/6/30
collection DOAJ
language English
format Article
sources DOAJ
author Olsson-Liljequist Barbro
Larsson Leif
Ringberg Håkan
Örtqvist Åke
Stenhem Mikael
Hæggman Sara
Ekdahl Karl
spellingShingle Olsson-Liljequist Barbro
Larsson Leif
Ringberg Håkan
Örtqvist Åke
Stenhem Mikael
Hæggman Sara
Ekdahl Karl
Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Sweden 2000–2003, increasing incidence and regional differences
BMC Infectious Diseases
author_facet Olsson-Liljequist Barbro
Larsson Leif
Ringberg Håkan
Örtqvist Åke
Stenhem Mikael
Hæggman Sara
Ekdahl Karl
author_sort Olsson-Liljequist Barbro
title Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Sweden 2000–2003, increasing incidence and regional differences
title_short Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Sweden 2000–2003, increasing incidence and regional differences
title_full Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Sweden 2000–2003, increasing incidence and regional differences
title_fullStr Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Sweden 2000–2003, increasing incidence and regional differences
title_full_unstemmed Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Sweden 2000–2003, increasing incidence and regional differences
title_sort epidemiology of methicillin-resistant staphylococcus aureus (mrsa) in sweden 2000–2003, increasing incidence and regional differences
publisher BMC
series BMC Infectious Diseases
issn 1471-2334
publishDate 2006-02-01
description <p>Abstract</p> <p>Background</p> <p>The occurrence of methicillin-resistant <it>Staphylococcus </it>aureus (MRSA) has gradually become more frequent in most countries of the world. Sweden has remained one of few exceptions to the high occurrence of MRSA in many other countries. During the late 1990s, Sweden experienced a large health-care associated outbreak which with resolute efforts was overcome. Subsequently, MRSA was made a notifiable diagnosis in Sweden in 2000.</p> <p>Methods</p> <p>From the start of being a notifiable disease in January 2000, the Swedish Institute for Infectious Disease Control (SMI) initiated an active surveillance of MRSA.</p> <p>Results</p> <p>The number of reported MRSA-cases in Sweden increased from 325 cases in 2000 to 544 in 2003, corresponding to an overall increase in incidence from 3.7 to 6.1 per 100000 inhabitants. Twenty five per cent of the cases were infected abroad. The domestic cases were predominantly found through cultures taken on clinical indication and the cases infected abroad through screening. There were considerable regional differences in MRSA-incidence and age-distribution of cases.</p> <p>Conclusion</p> <p>The MRSA incidence in Sweden increased over the years 2000–2003. Sweden now poises on the rim of the same development that was seen in the United Kingdom some ten years ago. A quarter of the cases were infected abroad, reflecting that international transmission is now increasingly important in a low-endemic setting. To remain in this favourable situation, stepped up measures will be needed, to identify imported cases, to control domestic outbreaks and to prevent transmission within the health-care sector.</p>
url http://www.biomedcentral.com/1471-2334/6/30
work_keys_str_mv AT olssonliljequistbarbro epidemiologyofmethicillinresistantstaphylococcusaureusmrsainsweden20002003increasingincidenceandregionaldifferences
AT larssonleif epidemiologyofmethicillinresistantstaphylococcusaureusmrsainsweden20002003increasingincidenceandregionaldifferences
AT ringberghakan epidemiologyofmethicillinresistantstaphylococcusaureusmrsainsweden20002003increasingincidenceandregionaldifferences
AT ortqvistake epidemiologyofmethicillinresistantstaphylococcusaureusmrsainsweden20002003increasingincidenceandregionaldifferences
AT stenhemmikael epidemiologyofmethicillinresistantstaphylococcusaureusmrsainsweden20002003increasingincidenceandregionaldifferences
AT hæggmansara epidemiologyofmethicillinresistantstaphylococcusaureusmrsainsweden20002003increasingincidenceandregionaldifferences
AT ekdahlkarl epidemiologyofmethicillinresistantstaphylococcusaureusmrsainsweden20002003increasingincidenceandregionaldifferences
_version_ 1724483502979678208